Pan-European Sarcoma Trials:Moving Forward in a Climate of Increasing Economic and Regulatory Pressure.
Advances in sarcoma treatment are largely based on investigator-initiated, multicentric and interdisciplinary clinical trials. The EU's Good Clinical Practice Directive 2001/20/EC, effective since 2004, was meant to harmonize the conditions for clinical trials across Europe, but, instead, the challe...
| Publicado en: | Sarcoma Vol. 2007; pp. 1 - 8 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=28652682&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 28652682 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1357714X 57R jtl: Sarcoma issn: 1357714X maglogo: Y pubinfo: dt: 2007 vid: 2007 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 28652682 10.1155/2007/76405 28652682 ppf: 1 ppct: 7 formats: fmt: @attributes: type: P tig: atl: Pan-European Sarcoma Trials:Moving Forward in a Climate of Increasing Economic and Regulatory Pressure. aug: au: Carrle, Dorothe Dantonello, Tobias Bielack, Stefan S. affil: Klinikum Stuttgart, Olgahospital, Paediatrics 5 (Oncology, Haematology, Immunology), D-70176 Stuttgart, Germany sug: ab: Advances in sarcoma treatment are largely based on investigator-initiated, multicentric and interdisciplinary clinical trials. The EU's Good Clinical Practice Directive 2001/20/EC, effective since 2004, was meant to harmonize the conditions for clinical trials across Europe, but, instead, the challenge of initiating and running multinational, noncommercial clinical trials has become greater than ever. Institutions participating in existing noncommercial Pan-European studies are struggling to cope with increased administrative and financial burdens, and few new studies are initiated any more. The aim of a conference entitled ‘Pan-European Sarcoma Trials: Moving Forward in a Climate of Increasing Economic and Regulatory Pressure,’ held in Stuttgart, Germany, 30 November-2 December 2006 as part of the European Science Foundation's ECT-program, was not only to provide an overview of currently active and plannedmultinational studies on osteo-, Ewing's, and soft tissue sarcoma, but also to draw on areas of synergy between various established sarcoma groups in Europe to define plausible survival strategies for collaborative, interdisciplinary, patient-oriented research. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|